More than a quarter of lung, uterine, and ovarian adenocarcinoma (LUAD, USEC, and OV) tumors are resistant to platinum drugs. Only recently and only in OV, patterns of copy-number alterations that predict survival in response to platinum were discovered, and only by using the tensor GSVD to compare Agilent microarray platform-matched profiles of patient-matched normal and primary tumor DNA. Here, we use the GSVD to compare whole-genome sequencing (WGS) and Affymetrix microarray profiles of patient-matched normal and primary LUAD, USEC, and OV tumor DNA. First, the GSVD uncovers patterns similar to one Agilent OV pattern, where a loss of most of the chromosome arm 6p combined with a gain of 12p encode for transformation. Like the Agilent OV pattern, the WGS LUAD and Affymetrix LUAD, USEC, and OV patterns are correlated with shorter survival, in general and in response to platinum. Like the tensor GSVD, the GSVD separates these tumor-exclusive genotypes from experimental inconsistencies. Second, by identifying the shorter survival phenotypes among the WGS- and Affymetrix-profiled tumors, the Agilent pattern proves to be a technology-independent predictor of survival, independent also of the best other indicator at diagnosis, i.e., stage. Third, like no other indicator, the pattern predicts the overall survival of OV patients experiencing progression-free survival, in general and in response to platinum. We conclude that comparative spectral decompositions, such as the GSVD and tensor GSVD, underlie a mathematically universal description of the relationships between a primary tumor's genotype and a patient's overall survival phenotype, which other methods miss.
Mathematically universal and biologically consistent astrocytoma genotype encodes for transformation and predicts survival phenotype.Version 2. APL Bioeng. 2018 Sep;2(3):031909. doi: 10.1063/1.5037882. Epub 2018 Sep 19. APL Bioeng. 2018. PMID: 30397684 Free PMC article.
Tensor GSVD of patient- and platform-matched tumor and normal DNA copy-number profiles uncovers chromosome arm-wide patterns of tumor-exclusive platform-consistent alterations encoding for cell transformation and predicting ovarian cancer survival.PLoS One. 2015 Apr 15;10(4):e0121396. doi: 10.1371/journal.pone.0121396. eCollection 2015. PLoS One. 2015. PMID: 25875127 Free PMC article.
Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition.PLoS One. 2016 Oct 31;11(10):e0164546. doi: 10.1371/journal.pone.0164546. eCollection 2016. PLoS One. 2016. PMID: 27798635 Free PMC article.
Medical therapy of advanced malignant epithelial tumours of the ovary.Forum (Genova). 2000 Oct-Dec;10(4):323-32. Forum (Genova). 2000. PMID: 11535983 Review.
Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review.Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):371-378. doi: 10.1016/j.bbagen.2018.11.005. Epub 2018 Nov 10. Biochim Biophys Acta Gen Subj. 2019. PMID: 30423357 Review.